Long-Term Safety Study of GS-6624 in Adults With Idiopathic Pulmonary Fibrosis (IPF)

Exclusion Criteria

• •History or evidence of clinically significant disorder, condition or disease that would pose a risk or interfere with the study
• •Pregnant or lactating
• •Clinically significant heart, hepatic or renal disease
• •History of cancer within 5 years of screening
• •Infection that is not controlled despite antibiotics or other treatment
• •History of bleeding diathesis within the last 6 months of Day 1
• •Known history of human immunodeficiency virus, hepatitis B or C
• •Concern's for subjects compliance
• •Other conditions that might put the subject at high risk for treatment complications or reduce the chance to obtain data required
• •Placed on a lung transplant list
• •Previous participation in an idiopathic pulmonary fibrosis clinical trial other than for simtuzumab